atropine has been researched along with 1,2-dimethylhydrazine in 2 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (1,2-dimethylhydrazine) | Trials (1,2-dimethylhydrazine) | Recent Studies (post-2010) (1,2-dimethylhydrazine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,388 | 1 | 290 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurkalo, VK | 1 |
| Darband, SG; Ghaderi-Pakdel, F; Majidinia, M; Mihanfar, A; Sadighparvar, S | 1 |
2 other study(ies) available for atropine and 1,2-dimethylhydrazine
| Article | Year |
|---|---|
[Neuropharmacologic regulation of the carcinogenic action of 1,2-dimethylhydrazine].
Topics: 1,2-Dimethylhydrazine; Adrenergic alpha-Antagonists; Animals; Atropine; Autonomic Nervous System; Carcinogens; Colonic Neoplasms; Dimethylhydrazines; Dioxanes; Guanethidine; Male; Methylhydrazines; Neoplasms, Experimental; Norepinephrine; Rats | 1981 |
Parasympathetic, but not sympathetic denervation, suppressed colorectal cancer progression.
Topics: 1,2-Dimethylhydrazine; Animals; Atropine; Carcinogenesis; Carcinogens; Colon; Colorectal Neoplasms; Disease Progression; Ganglia, Sympathetic; Ganglionectomy; Guanethidine; Humans; Male; Mesentery; Neoplasms, Experimental; Parasympathetic Nervous System; Rats; Rats, Wistar; Vagotomy | 2021 |